FORMULATION AND OPTIMIZATION OF GASTRO-RETENTIVE FLOATING TABLETS OF ENALAPRIL MALEATE AND LOSARTAN FOR ENHANCED BIOAVAILABILITY AND THERAPEUTIC EFFICACY
Keywords:
Floating tablets, Enalapril Maleate, Losartan, Bioavailability, GRDDSAbstract
The objective of this study was to formulate and optimize gastro-retentive floating tablets of Enalapril Maleate and Losartan to enhance their bioavailability and therapeutic efficacy. These drugs, commonly used in the management of hypertension and heart failure, suffer from limited solubility and rapid gastric emptying, which reduce their effectiveness. Gastro-retentive floating tablets were developed using hydroxypropyl methylcellulose (HPMC K4M) and guar gum as release-controlling agents, with sodium bicarbonate and citric acid as effervescent agents to ensure buoyancy. Twenty formulations were prepared using the direct compression method and evaluated for critical parameters, including hardness, friability, swelling index, floating lag time, total floating time, and in-vitro drug release.
Preformulation studies confirmed the compatibility of the drugs with excipients, with no chemical interactions detected using FTIR spectroscopy. The micrometric properties of the powder blends demonstrated excellent flowability and compressibility, ensuring suitability for tablet manufacturing. All formulations showed acceptable weight variation, hardness, and friability. The floating lag time ranged from 4.3 to 5.1 minutes, and total floating times exceeded 8 hours for all batches. Drug content ranged from 96.79% to 99.57%, reflecting uniformity and accuracy in dosing.
In-vitro dissolution studies revealed sustained release profiles, with optimized formulations achieving over 90% cumulative drug release within 12 hours. Batch F7 demonstrated the best overall performance, with a high swelling index, minimal floating lag time, prolonged floating duration, and consistent drug release. These findings indicate that gastro-retentive floating tablets of Enalapril Maleate and Losartan can effectively address challenges associated with poor bioavailability and rapid gastric emptying, offering a promising approach for improved therapeutic outcomes and patient compliance.
Downloads
References
Yeole PG, Khan S, Patel VF. Floating drug delivery systems: Need and development. Indian J Pharm Sci. 2005;67(3):265.
Sharma N, Agarwal D, Gupta MK, Khinchi M. A comprehensive review on floating drug delivery system. Int J Res Pharm Biomed Sci. 2011;2(2):428-441.
Graffner C, Johansson ME, Nicklasson M, Nyqvist H. Preformulation studies in a drug development program for tablet formulations. J Pharm Sci. 1985;74(1):16-20.
Lee BJ. Pharmaceutical preformulation: Physicochemical properties of excipients and powders and tablet characterization. Pharm Sci Encycl Drug Discov Dev Manuf. 2010;1-54.
BG P, Mishra O. Concept, Manufacturing and Characterization of Effervescent Tablets: A Review.
Parida DR, Kharia AA, Choudhary NK. Recent Trends in Floating Drug Delivery System. Res J Pharm Technol. 2022;15(1):429-435.
Sravya V, Patro J, Ch S. Formulate gastroretentive floating bioadhesive drug delivery system of nizatidine by direct compression technique. World J Pharm Sci. 2022;59-73.
Kothule S, Aher S, Bachhav R. Formulation Development and Evaluation of Gastroretentive Floating Tablet of Vildagliptin.
Özdoğan AI, Akca G, Şenel S. Development and in vitro evaluation of gel formulation of atorvastatin solid dispersions. J Drug Deliv Sci Technol. 2021;61:102199.
Kumar A, Srivastava R. In vitro In Vivo Studies On Floating Microspheres For Gastroretentive Drug Delivery System: A Review. Asian J Pharm Clin Res. 2021;13-26.
Rahamathulla M, Hani U, Alqahtani A, HV G, Begum Y, Jaffer M, Osmani RAM, Chidambaram K, Moin A, Shankar SJ. 23 Factorial Design and Optimization of Effervescent Floating Matrix Tablet of Neratinib. J Pharm Innov. 2021;1-12.
Rajora A, Nagpal K. A Critical Review on Floating Tablets as a Tool for Achieving Better Gastric Retention. Crit Rev Ther Drug Carrier Syst. 2022;39(1).
Dhone PG, Sahu YP, Sabitri B, Khandelwal PN. Formulation and evaluation of floating tablet of levofloxacin.
Israr M, Pugliese N, Farid A, Ghazanfar S, Di Cerbo A, Muzammal M, Alamri AS, Basheeruddin Asdaq SM, Ahmad A, Khan KA. Preparation and Characterization of Controlled-Release Floating Bilayer Tablets of Esomeprazole and Clarithromycin. Molecules. 2022;27(10):3242.
Ashish D, Vibhu S. Formulation and Evaluation of Floating Tablet of Thiocolchicoside. Curr Res Pharm Sci. 2022;59-67.
Ahirrao S, Bhambere D, Todkar K, Patil M, Khairnar P, Udavant P. Formulation Development and Evaluation of Floating Tablets of Zolmitriptan. Biosci Biotechnol Res Asia. 2022;19(2):395-405.
Nijhu RS. Formulation and in vitro evaluation of bilayer floating tablet of Aceclofenac and esomeprazole by using natural and synthetic polymer.
Desai D, Masareddy R, Patil A, Desai S, Matt VK. Formulation, optimization and validation of floating oral in situ gel of Ivabradine hydrochloride. Ther Deliv. 2022;May(0).
Arshad MS, Kiran M, Mudassir J, Farhan M, Hussain A, Abbas N. Formulation, Optimization, in vitro and in-vivo evaluation of levofloxacin hemihydrate Floating Tablets. Brazilian Journal of Pharmaceutical Sciences. 2022 Mar 14;58.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Tropical Journal of Pharmaceutical and Life Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.